Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajita P De

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2007
Nuclear medicine scientists: findings and recommendations based on a 2006 surveyPaul Wing, Margaret H Langelier, Ajita P De
Drugs in Context|January 17, 2014
Probabilistic data linkage: a case study of comparative effectiveness in COPDChristopher M Blanchette, Mitch Dekoven, Ajita P De, et al.
Journal of Managed Care & Specialty Pharmacy|July 25, 2017
Evaluation of Patient Migration Patterns and Related Health Care Costs Within a National Medicare Advantage Prescription Drug Plan After Implementation of an Oxycodone HCl Extended-Release Access RestrictionChi-Chang Chen, Ajita P De, Brian Sweet, et al.
Journal of Health Economics and Outcomes Research|September 4, 2023
Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare PlansRolin L Wade, Chi-Chang Chen, Ajita P De, et al.
Journal of Medical Economics|June 4, 2014
Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plansRami Ben-Joseph, Chi-Chang Chen, Ajita P De, et al.
The American Journal of Managed Care|July 19, 2018
Two-year adherence and costs for biologic therapy for rheumatoid arthritisBradley S Stolshek, Sally Wade, Alex Mutebi, et al.
Journal of Managed Care & Specialty Pharmacy|August 31, 2017
Estimation of Missed Statin Prescription Use in an Administrative Claims DatasetRolin L Wade, Jeetvan G Patel, Jerrold W Hill, et al.
Journal of Health Economics and Outcomes Research|May 27, 2022
Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor MonotherapyGeorge Ruiz, Jason Yeaw, Cassandra A Lickert, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 13, 2013
Synchronization of administrations of chemotherapy and erythropoiesis-stimulating agents and frequency of associated healthcare visitsJerrold W Hill, Sanatan Shreay, November McGarvey, et al.
Hormone Research in Paediatrics|February 22, 2014
Association of cord blood leptin, soluble leptin receptor, insulin-like growth factor-I and insulin-like growth factor-binding protein-1 on birth indices in healthy full-term newbornsKamani H Tennekoon, Jayanthiny Poopalapillai, Akila G Karunanayake, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2007
Nuclear medicine scientists: findings and recommendations based on a 2006 surveyPaul Wing, Margaret H Langelier, Ajita P De
Drugs in Context|January 17, 2014
Probabilistic data linkage: a case study of comparative effectiveness in COPDChristopher M Blanchette, Mitch Dekoven, Ajita P De, et al.
Journal of Managed Care & Specialty Pharmacy|July 25, 2017
Evaluation of Patient Migration Patterns and Related Health Care Costs Within a National Medicare Advantage Prescription Drug Plan After Implementation of an Oxycodone HCl Extended-Release Access RestrictionChi-Chang Chen, Ajita P De, Brian Sweet, et al.
Journal of Health Economics and Outcomes Research|September 4, 2023
Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare PlansRolin L Wade, Chi-Chang Chen, Ajita P De, et al.
Journal of Medical Economics|June 4, 2014
Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plansRami Ben-Joseph, Chi-Chang Chen, Ajita P De, et al.
The American Journal of Managed Care|July 19, 2018
Two-year adherence and costs for biologic therapy for rheumatoid arthritisBradley S Stolshek, Sally Wade, Alex Mutebi, et al.
Journal of Managed Care & Specialty Pharmacy|August 31, 2017
Estimation of Missed Statin Prescription Use in an Administrative Claims DatasetRolin L Wade, Jeetvan G Patel, Jerrold W Hill, et al.
Journal of Health Economics and Outcomes Research|May 27, 2022
Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor MonotherapyGeorge Ruiz, Jason Yeaw, Cassandra A Lickert, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 13, 2013
Synchronization of administrations of chemotherapy and erythropoiesis-stimulating agents and frequency of associated healthcare visitsJerrold W Hill, Sanatan Shreay, November McGarvey, et al.
Hormone Research in Paediatrics|February 22, 2014
Association of cord blood leptin, soluble leptin receptor, insulin-like growth factor-I and insulin-like growth factor-binding protein-1 on birth indices in healthy full-term newbornsKamani H Tennekoon, Jayanthiny Poopalapillai, Akila G Karunanayake, et al.
Pageof 1